Aron Berhanie Abera
Total Page:16
File Type:pdf, Size:1020Kb
The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgementTown of the source. The thesis is to be used for private study or non- commercial research purposes only. Cape Published by the University ofof Cape Town (UCT) in terms of the non-exclusive license granted to UCT by the author. University CHARACTERIZATION OF SIGNALLING CROSS-TALK BETWEEN THE EP2 AND FP RECEPTORS IN ENDOMETRIAL EPITHELIAL CELLS ARON BERHANIE ABERA B.tech (Medial Biotechnology), Cape Peninsula University of Technology B.Sc (Hons) (Human Genetics), University of the Cape Town M.Sc (Medicine), University of the Cape Town Department of Medical Biochemistry University of Cape Town Medical School Anzio Road Observatory Town 7925 South Africa and Cape of Human Reproductive Sciences Unit Medical Research Council The Queen’s Medical Research Institute 47 Little France Crescent Edinburgh EH16 4TJ UK University Thesis presented for the Degree of DOCTOR OF PHILOSOPHY in the Division of Medical Biochemistry UNIVERSITY OF CAPE TOWN August, 2009 DECLARATION I herewith declare that I autonomously carried out this work, except where due acknowledgements is made by reference. No portion of this work has been previously accepted for, or is currently being submitted in candidature for another degree. Aron B Abera August, 2009 Town Cape of University VII ACKNOWLEDGEMENTS This thesis is the culmination of study conducted between the Receptor Biology group (RBG), South Africa and the Human Reproductive Science Unit (HRSU), UK. I am very grateful to Prof Bob Millar for establishing this collaboration between the two countries and I thoroughly enjoyed interacting and working with different people. I would like to express my sincere thanks to my supervisors, Profs Arieh Katz and Henry Jabbour for their guidance throughout the duration of the project. Special appreciation is due to Kurt for his help in every aspect of my project starting from my first experiment in Edinburgh to submission of my paper. I would also like to thank Roberto Catalano for his help and advice on the Gene array work. Town I would like to thank all the members of the HRSU; you have been great colleagues and even better friends and without you I wouldn’t have survived the cold weather in Edinburgh. I would like to thankCape all my friends for their supports and encouragements. Special mention goesof to Kim who has been kind and understanding all these years. I would also like to thank Eden, Nerine, Marla, Pumza, Michael, Javier, Dereje, Zekarias, Mushi, Valerie and Jackson who have contributed for the completion of this project in different ways. I would like to extend special thanks to my laboratory colleagues in RBG, Cape Town and in HRSU, Edinburgh (especially to Sharon) for their friendly assistance throughout the project. I would like to thank to my funders, Department ofUniversity Medical Biochemistry of UCT and the MRC unit both in South Africa and UK. Last, but not least, I would like to thank all my family members for being patient with me and for their unconditional love. Special mention goes out to my late brother Yonas, I wish you were here with me and I always think of you. VIII PUBLICATION AB Abera, KJ Sales, RD Catalano, AA Katz and HN Jabbour. EP2 receptor-mediated cAMP release is augmented following activation of the calcium-calmodulin pathway by PGF2α-FP receptor interaction. Submitted to Cellular Signalling journal CONFERNCE PROCEEDING AB Abera, KJ Sales, RD Catalano, AA Katz and HN Jabbour (2008). EP2 receptor- mediated cAMP release is augmented following activationTown of the calcium-calmodulin st pathway by PGF2α-FP receptor interaction. 41 Annual Meeting of the Society for the Study of Reproduction, Kailua-Kona, Hawaii (Abstract no197). Cape of University IX LIST OF ABBREVIATIONS AA arachidonic acid AC adenylyl cyclase AKR aldo-keto reductase ALP alkaline phosphatase AMPS ammonium persulphate ANG angiotensin Ang-1 angiopoietin-1 Ang-2 angiopoietin-2 ANOVA analysis of variance ATP adenosine triphosphate β-AR β-adrenergic BCP 1-bromo-3-chloropropane bFGF basic fibroblast growth factor bp base pairs BSA bovine serum albumin Town CaMBD calmodulin binding domain CAMK-II Ca2+/calmodulin-dependent kinase II cAMP adenosine 3’,5’-cyclic monophosphate cDNA complementary DNA CHO Chinese hamster ovary Cape CIS carcinoma in situ COX cyclooxygenase of CRE cAMP response element CREB cAMP regulatory binding protein DAG diacylglycerol DEPC diethylpyrocarbonate dH2O distilled water DMEM dulbecco's modified eEagle medium DMSO dimethylsulphoxide DNA deoxyribonucleic acid dNTP Universitydeoxyribonucleotide triphosphates EC50 median (half-maximal) effective concentration ECM extracellular matrix EDTA ethylenediamine tetraacetic acid EGF endothelial growth factor EGFR epidermal growth factor receptor EIC endometrial intraepithelial carcinoma ELISA enzyme-linked immunosorbent assay ER endoplasmic reticulum ERK extracellular signal-regulated kinase Emax maximal agonist-stimulated IP production FAK focal adhesion kinase X FCS foetal calf serum FGF fibroblast growth factor FSH follicle-stimulating hormone G protein guanine nucleotide-binding protein GAPDH glyceraldehyde-3-phosphate dehydrogenase GPCR G protein-coupled receptor GSK-3 glycogen synthase kinase-3 GTP guanosine triphosphate HEK-293 human embryonic kidney-293 HEL human erythroleukemia HEPES N-2-Hydroxyethylpiperazine-N’-2-ethanesulfonic acid HRP horse-radish peroxidise Hyg hygromycin IBMX 3-isobutyl-1-methyl xanthine IGF insulin growth factor IgG Immunoglobulin G IHC immunohistochemistry IL interleukin Town IM intramural IP3 inositol phosphate JAK janus-activated kinase KDa kilodalton LH luteinizing hormone Cape mg milligram l microgram of ml milliliter g microlitre MAPK mitogen-activated protein kinase MMP matrixmetalloproteinases mRNA messenger ribonucleic acid NF B nuclear factor-kappaB NP40 “Nonidet” P40 NSAID Universitynon-steroidal anti-inflammatory drug OSE ovarian surface epithelial OH hydroxyl PAGE polyacrylamide gel electrophoresis PBS phosphate buffered saline PCR polymerase chain reaction PDGF platelet derived growth factor PFA paraformaldehyde PG prostaglandins PGD2 prostaglandin D2 PGE2 prostaglandin E2 PGES prostaglandin E synthase XI PGF2 prostaglandin F2 PGFS prostaglandin F synthase PGG2 prostaglandin G2 PGH2 hydroxy cyclic endoperoxide PGI2 prostacyclin PGT prostaglandin transporter PI3K phosphatidylinositol 3-kinase PKC protein kinase C PLA2 phospholipase A2 PLC phospholipase C PPAR peroxisome proliferators-activated receptors PTEN phosphatase and tensin homolog on chromosome ten PVDF polyvinylidene difluoride 2+ RACC receptor-activated Ca channel Rb retinoblastoma rpm revolutions per minute RT reverse transcriptase RTK receptor tyrosine kinase Town SAT1 spermidine/ N1-acetyltransferase SDS sodium dodecyl sulphate SEM standard error of the mean siRNA small interfering RNA SM submucosal Cape SS subserosal STAT signal transducers andof activators of transcription TAE tris-acetate EDTA Taq thermus aquaticus TBE tris-boric acid EDTA TBS tris-buffered saline TBST tris-buffered saline with Tween®20 TGF transforming growth factor TM transmembrane TNF tumour necrosis factor Tris Universitytris (hydroxymethyl) amino methane TRP transient receptor potential TXA2 thromboxane A2 UV ultraviolet V volt VEGF vascular endothelial growth factor W watt XII LIST OF FIGURES Fig. 1.1: The arachidonic acid metabolism. ....................................................................... 4 Fig.1.2: Schematic representation of cyclooxygenase-prostanoid biosynthetic and signalling pathway. ........................................................................................................... 12 Fig. 1.3: Histological classification of endometrial cancer. ............................................ 28 Fig. 1.4: Different locations of uterine fibroids. ............................................................... 34 Fig. 1.5: Adenylyl cyclase structure. ................................................................................ 41 Fig. 3.1: Relative mRNA expression of COX-1 and COX-2 in fibroids and adjacent myometrium tissue homogenates from women with fibroids. ........................................... 70 Fig. 3.2: Relative mRNA expression of prostanoid receptors (EP1, EP2, EP3, EP4, FP receptors) and prolactin in fibroids and adjacent myometrium tissue homogenates. ...... 72 Fig. 3.3: Relative mRNA expression of COX-1 and COX-2Town in endometrium tissue homogenates from women with and without fibroids. ..................................................... 73 Fig. 3.4: Relative mRNA expression of EP2, EP4 and FP receptors in endometrium tissue homogenates from women with and without Capefibroids. ...................................................... 75 Fig. 3.5: Relative mRNA expression of VEGF, IL -8 and IL-11 in endometrium tissue homogenates from women with and withoutof fibroids. ..................................................... 77 Fig. 4.1: Relative expression EP1, EP2, EP3, EP4 and FP prostanoid receptors in FPS32, FPEP2 clone 4, 8 and 10. ................................................................................................. 91 Fig. 4.2: The effects of 5 and 10 min treatment with vehicle, Butaprost or PGE on cAMP release in FPS32, FPEP2 clone 4 and 8 cell lines. .......................................................... 93 Fig. 4.3: The effect of 1 hr PGF stimulation on IP3 response in FPS32 and FPEP2 clone 8 cell lines.